Advertisement
Screener

AMICUS THERAPEUTICS, INC. Patents: Active

AMICUS THERAPEUTICS, INC. Active Patents

48 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2023-06-26: Application 18214002; Invention Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The Same; Applicant Amicus Therapeutics, Inc.; Status Patented Case.
  • 2023-05-31: Application 18326281; Invention Methods Of Treating Fabry Patients Having Renal Impairment; Applicant Amicus Therapeutics, Inc.; Status Patented Case.
  • 2023-05-31: Application 18326279; Invention Methods Of Treating Fabry Patients Having Renal Impairment; Applicant Amicus Therapeutics, Inc.; Status Patented Case.
  • 2023-05-31: Application 18326274; Invention Methods Of Treating Fabry Patients Having Renal Impairment; Applicant Amicus Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2023-06-2618214002Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The SameAmicus Therapeutics, Inc.Patented Case2025-04-1512275703US20230348388A1
Kamlesh Sheth
Sergey Tesler
James Cartwright
Clive King
Wendy Cross
United States
United States
United Kingdom
United Kingdom
United Kingdom
SEAMAN, D MARGARET M
2023-05-3118326281Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2024-07-2312042490US20230381165A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2023-05-3118326279Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2024-07-2312042489US20240122911A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2023-05-3118326274Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2024-07-2312042488US20230381164A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2023-05-1818199125Dosing Regimens for the Treatment of Lysosomal Storage Diseases Using Pharmacological ChaperonesAmicus Therapeutics, Inc.Patented Case2026-04-1412599595US20230364071A1
Jeff Castelli
David J. Lockhart
United States
United States
LEWIS, PATRICK T
2023-05-1818199120Treatment Of Fabry Disease In ERT-Naïve And ERT-Experienced PatientsAmicus Therapeutics, Inc.Patented Case2026-04-1412599594US20230321065A1
Jeff Castelli
United States
LEWIS, PATRICK T
2022-12-2118069732Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2025-04-2212280042US20230218599A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-12-2118069720Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2023-10-1711786516US20230218598A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-12-2118069716Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2023-11-1411813255US20230201180A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-11-0718053151FORMULATIONS COMPRISING RECOMBINANT ACID ALPHA-GLUCOSIDASEAmicus Therapeutics, Inc.Patented Case2026-05-1212622952US20240066104A1
Hing Char
Sergey Tesler
Wendy Sunderland
Enrique Diloné
Russell Gotschall
Hung V. Do
United States
United States
United States
United States
United States
United States
CHOWDHURY, IQBAL HOSSAIN
2022-09-1217931351Method For Selection Of High M6P Recombinant ProteinsAmicus Therapeutics, Inc.Patented Case2026-07-2112686859US20230079225A1
Hung V. Do
Russell Gotschall
United States
United States
CHOWDHURY, IQBAL HOSSAIN
2022-06-1317838817Compositions For Preventing And/Or Treating Degenerative Disorders Of The Central Nervous System And/Or Lysosomal Storage DisordersAmicus Therapeutics, Inc.Patented Case2026-02-1712552736US20220306568A1
Robert Boyd
United States
MURESAN, ANA Z
2022-03-2117699927AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASEAmicus Therapeutics, Inc.Patented Case2025-09-1612414985US20220370571A1
Hung V. DO
Richie KHANNA
Russell GOTSCHALL
United States
United States
United States
MONSHIPOURI, MARYAM
2022-03-2117699910HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASEAmicus Therapeutics, Inc.Patented Case2025-09-2312419937US20220347272A1
Kenneth Valenzano
John Crowley
Richie Khanna
John Flanagan
United States
United States
United States
United States
UNDERDAHL, THANE E
2022-02-1817675587Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-07-1911389437US20220168292A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1817675544Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-10-0411458128US20220168291A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1817675536Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2023-06-0611666564US20220387406A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1817675532Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-07-1911389436US20220168290A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1117670095Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-07-0511376244US20220168289A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1117670088Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-06-1411357765US20220160691A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1117670083Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-06-1411357764US20220168288A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-1117670076Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-08-3011426396US20220168287A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2022-02-0417665179HIGHLY POTENT ACID ALPHA-GLUCOSIDASE WITH ENHANCED CARBOHYDRATESAmicus Therapeutics, Inc.Patented Case2023-02-2811591583US20220162578A1
Russell GOTSCHALL
Hung V. DO
United States
United States
KOMATSU, LI N
2022-01-3117588943Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA GeneAmicus Therapeutics, Inc.Patented Case2025-09-1612414944US20220142998A1
Elfrida Benjamin
United States
WEDDINGTON, KEVIN E
2021-12-1517551806HIGHLY PURIFIED BATCHES OF PHARMACEUTICAL GRADE 1-DEOXYGALACTONOJIRIMYCIN COMPOUNDSAmicus Therapeutics, Inc.Patented Case2023-06-2711685718US20220194899A1
Kamlesh Sheth
Sergey Tesler
James Cartwright
Clive King
Wendy Cross
United States
United States
United Kingdom
United Kingdom
United Kingdom
SEAMAN, D MARGARET M
2021-08-1317401629Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-03-2211278540US20210379037A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400932Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-06-1411357763US20220105079A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400927Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-03-2211278539US20210379036A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400922Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-03-2211278538US20210386723A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400626Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-03-2211278537US20210393603A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400623Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-03-2211278536US20210379035A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400614Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-06-1411357762US20210379034A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-1217400548Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-06-1411357761US20210393602A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-08-0417393971Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2022-04-1911304940US20210361633A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-07-3029801769Drug PackageAmicus Therapeutics, Inc.Patented Case2025-08-12D1087752
Sameeha Hussain
Timothy Pribilski
United States
United States
ALEXAKIS, CHARITON
2021-07-3029801766DRUG PACKAGEAmicus Therapeutics, Inc.Patented Case2025-07-08D1082532
Sameeha Hussain
Timothy Pribilski
United States
United States
DIEHL, JOAN ELIZABETH
2021-06-3017363333DISULFIDE BOND STABILIZED POLYPEPTIDE COMPOSITIONS AND METHODS OF USEAmicus Therapeutics, Inc.Patented Case2024-08-2012064485US20220023443A1
Hung Do
Ce Feng Liu
United States
United States
CHEN, SHIN LIN
2021-03-2617213632Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2024-02-2011903938US20210220344A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2021-02-2317249175HIGHLY POTENT ACID ALPHA-GLUCOSIDASE WITH ENHANCED CARBOHYDRATESAmicus Therapeutics, Inc.Patented Case2023-09-1211753632US20210261935A1
Russell Gotschall
Hung V. Do
United States
United States
KOMATSU, LI N
2021-02-1917269890Methods of Treating Fabry Disease in Patients Having a Mutation in the GLA GeneAmicus Therapeutics, Inc.Patented Case2026-04-0712594268US20210315875A1
Elfrida Benjamin
United States
BRAUN, MADELINE E
2021-01-1417148817Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The SameAmicus Therapeutics, Inc.Patented Case2023-04-1111623916US20220185776A1
Kamlesh Sheth
Sergey Tesler
James Cartwright
Clive King
Wendy Cross
United States
United States
United Kingdom
United Kingdom
United Kingdom
SEAMAN, D MARGARET M
2020-10-2217077402Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2023-04-1111622962US20210069162A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2020-01-1616744884Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA GeneAmicus Therapeutics, Inc.Patented Case2022-02-0111234972US20200215043A1
Elfrida Benjamin
United States
WEDDINGTON, KEVIN E
2019-07-0916476751Recombinant Alpha-Galactosidase A For Treatment Of Fabry DiseaseAMICUS THERAPEUTICS, INC.Patented Case2022-06-1411357834US20190358302A1
Russell GOTSCHALL
United States
STEADMAN, DAVID J
2019-01-1816318905TREATMENT OF FABRY DISEASE IN ERT-NAÏVE AND ERT-EXPERIENCED PATIENTNAmicus Therapeutics, Inc.Patented Case2024-08-2712070453US20190183869A1
Jeff Castelli
United States
LEWIS, PATRICK T
2018-09-1416131904Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA GeneAmicus Therapeutics, Inc.Patented Case2020-01-2110537564US20190000819A1
Elfrida Benjamin
United States
CHU, YONG LIANG
2018-05-3015992336Methods Of Treating Fabry Patients Having Renal ImpairmentAmicus Therapeutics, Inc.Patented Case2019-04-0910251873US20180344712A1
Jeff Castelli
Elfrida Benjamin
United States
United States
HENLEY III, RAYMOND J
2017-03-1515459149Methods Of Treating Fabry Disease In Patients Having The G9331A Mutation In The GLA GeneAmicus Therapeutics, Inc.Patented Case2018-09-1810076514US20170273959A1
Elfrida Benjamin
United States
CHU, YONG LIANG